📰 05b2 News
05b2 News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from 05b2. Real-time updates on events, politics, business and more.
April 18, 2023
Additional extractable & leachable data generated by an accredited lab facility located in North AmericaResults analyzed and evaluated by toxicological...
January 24, 2023
Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia,...
May 4, 2022
Petros Pharmaceuticals, Inc. announces today they will be pursuing the 505(b)(2) pathway for its investigational agent, H-100™, a novel, patented, non-invasive topical treatment being developed for Peyronie’s disease, a condition impacting more than 1 in 10 men in the US.
May 3, 2022
Company Is Developing H-100 as Potentially the First FDA-Approved, Nanoparticle-Based Topical Treatment Designed to Provide Improved and Sustained Local...